8 events about "АстраЗенека"

11 October 08:16

AstraZeneca has announced significant reductions for medications sold in the United States, following an agreement made with the Trump administration.

Sources

International

6 October 12:44

AstraZeneca has signed a 555 million dollar agreement with Algen for the development of therapies based on Crispr technology, specialized in artificial intelligence.

Sources

Economy

30 September 09:18

AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.

Sources

International

14 September 06:12

AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.

Sources

Economy

23 July 08:20

AstraZeneca will invest 50 billion dollars to expand manufacturing and research in the US, including a new plant in Virginia for anti-obesity treatments.

Sources

+2

International

3 July 08:05

AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.

Sources

Economy

2 June 06:41

An experimental pill from AstraZeneca has shown a 56% reduction in the risk of breast cancer progression, according to a study presented at ASCO

Sources

Health

19 March 12:18

AstraZeneca is buying Fusion Pharmaceuticals, a Canadian company specializing in radioconjugation cancer treatments, for $2.4 billion.

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge